USES SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using …

May 8, 2025 · What is the best medicine for ulcerative colitis? The treatment options for ulcerative colitis vary based on the disease’s severity and can be categorized into six main types: …

Jun 18, 2024 · The most common side effects of SKYRIZI in people treated for Crohn's disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach …

Jul 23, 2024 · As a treatment for ulcerative colitis, Skyrizi works by fighting the inflammation that can lead to symptoms of the disease.

Nov 8, 2025 · Yes, SKYRIZI is used for ulcerative colitis. Learn about its recent FDA approval, how this IL-23 inhibitor works, and what clinical studies show about its effectiveness for …

SKYRIZI® is indicated for the treatment of moderately to severely active ulcerative colitis in adults. See Important Safety and Prescribing Information.

Jun 19, 2024 · The US Food and Drug Administration (FDA) has approved Skyrizi (risankizumab-rzaa; AbbVie) for the treatment of moderately to severely active ulcerative colitis in adults. This …

Skyrizi (risankizumab-rzaa) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderately to severely active Crohn’s disease in adults. It’s also …

Jun 20, 2024 · The FDA has given its okay to the biologic drug Skyrizi (risankizumab) as a treatment for people with moderately to severely active ulcerative colitis. The medication works …

Patients should be evaluated for tuberculosis (TB) prior to starting this medication, and should not be given Skyrizi® if there is active TB. If there is a hypersensitivity reaction or anaphylaxis …